Cellular, animal and computational models of the disease are providing fresh insights into biology and treatment.

The order of cancer-driving mutations—genetic changes—plays an important role in whether tumors in the intestine can develop, ...

Cancer is a leading cause of death worldwide, and among all cancers, colorectal cancer ranks second in mortality, responsible ...

This pilot project evaluated whether targeted training could strengthen clinical research capacity at community cancer centers, improve readiness to conduct oncology trials, and support more inclusive ...

CorriXR Therapeutics, an oncology-focused biotherapeutics company pioneering a ground-breaking gene editing platform technology, InhaTarget Therapeutics, a company dedicated to the early development ...

Researchers say this is the first combination therapy that targets two different cancer survival mechanism: PARP and WNT signaling.

A new MD Anderson antibody, 77A, restores treatment response in resistant myeloma, lymphoma and solid tumors, offering a ...

MS. COOPER: Good morning, and welcome to The Washington Post. I’m Gina Cooper, managing director of Washington Post Live. Thank you so much to everyone who’s here in the room joining us this morning ...

Diakonos Oncology gets grant from Cancer Prevention and Research Institute of Texas to advance DOC1021 in refractory melanoma: Houston Friday, December 12, 2025, 13:00 Hrs [IST] D ...

Lunit (KRX:328130), a leading provider of AI for cancer diagnostics and precision oncology, today announced that it has ...

Researchers have reported initial findings from a public-private partnership between the ECOG-ACRIN Cancer Research Group and ...

Shanghai Henlius Biotech, Inc. Class H ( ($HK:2696) ) has issued an update. Shanghai Henlius Biotech, Inc. announced the approval of phase 2/3 ...